{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T16:18:54Z","timestamp":1793636334751,"version":"4.5.1"},"reference-count":54,"publisher":"Bentham Science Publishers Ltd.","issue":"9","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MC"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Bioisosterism is a unique approach used by medicinal chemists for the reasonable modification\nof lead compounds into safer, more clinically effective, economical, and therapeutically attractive\ndrugs. It is one of the most crucial lead modification tools, widely applied in the field of rational\ndrug design to amplify the desired activity and eliminate undesirable properties, thus facilitating the\noptimization of pharmacokinetic profile and achievement of target selectivity. This review demonstrates\nthe importance of bioisosterism in the process of drug discovery and development and highlights\nits relevance in the molecular evolution of many classes of drugs such as antibacterial sulfonamides,\nanticancer drugs, antivirals, antifungals, anthelmintics, local anesthetics, barbiturates, antidepressants,\nantihistamines, proton pump inhibitors and work carried out by our team of researchers.\nThe role of bioisosterism as a strategy to achieve inhibition of enzymes such as thymidylate synthase,\nDNA polymerase, reverse transcriptase and several others has also been pointed out. There are no\nlimits to the classes of drugs where bioisosterism has been successfully applied.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573406418666220127124228","type":"journal-article","created":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T08:10:06Z","timestamp":1643357406000},"page":"915-925","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Bioisosterism in Drug Discovery and Development - An Overview"],"prefix":"10.2174","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1729-5805","authenticated-orcid":true,"given":"B.S.","family":"Jayashree","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher\nEducation, Manipal, Karnataka-576104, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Sai","family":"Nikhil","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher\nEducation, Manipal, Karnataka-576104, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7982-2426","authenticated-orcid":true,"given":"Soumyajeet","family":"Paul","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher\nEducation, Manipal, Karnataka-576104, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1021\/jf5054707","volume":"64","author":"Liu C.","year":"2016","unstructured":"Liu C.; Guan A.; Yang J.; Chai B.; Li M.; Li H.; Efficient approach to discover novel agrochemical candidates: Intermediate derivatiza-tion method. J Agric Food Chem 2016,64(1),45-51","journal-title":"J Agric Food Chem"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1021\/ja953172i","volume":"118","author":"Singh J.","year":"1996","unstructured":"Singh J.; Ator M.A.; Jaeger E.P.; Allen M.P.; Whipple D.A.; Soloweij J.E.; Application of genetic algorithms to combinatorial synthesis: A computational approach to lead identification and lead optimization. J Am Chem Soc 1996,118(7),1669-1676","journal-title":"J Am Chem Soc"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1021\/ci0100806","volume":"42","author":"Sheridan R.P.","year":"2002","unstructured":"Sheridan R.P.; The most common chemical replacements in drug-like compounds. J Chem Inf Comput Sci 2002,42(1),103-108","journal-title":"J Chem Inf Comput Sci"},{"key":"ref=4","author":"Wipf P.","year":"2008","unstructured":"Wipf P.;  Bioisosterism allows modification of physicochemical parameters 2008","journal-title":"Bioisosterism allows modification of physicochemical parameters"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.bmcl.2009.10.061","volume":"20","author":"Wang H.","year":"2010","unstructured":"Wang H.; Byun Y.; Barinka C.; Pullambhatla, M Bioisosterism of urea-based GCPII inhibitors: Synthesis and structure-activity relation-ship studies. Bioorg Med Chem Lett 2010,20(1),392-397","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1021\/acs.jcim.0c00290","volume":"60","author":"Ertl P.","year":"2020","unstructured":"Ertl P.; Identification of bioisosteric substituents by a deep neural network. J Chem Inf Model 2020,60(7),3369-3375","journal-title":"J Chem Inf Model"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2174\/0929867053363540","volume":"12","author":"Lima L.","year":"2012","unstructured":"Lima L.; Barreiro E.; Bioisosterism: A useful strategy for molecular modification and drug design. Curr Med Chem 2012,12(1),23-49","journal-title":"Curr Med Chem"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1021\/ja02231a009","volume":"41","author":"Irving Langmuir B.","year":"1919","unstructured":"Irving Langmuir B.; Isomorphism, isosterism and covalence. J Am Chem Soc 1919,41(10),1543-1559","journal-title":"J Am Chem Soc"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/9783527654307.ch1","author":"Brown N.","year":"2012","unstructured":"Brown N.;  Bioisosteres in Medicinal Chemistry 2012,1-14","journal-title":"Bioisosteres in Medicinal Chemistry"},{"key":"ref=10","first-page":"31","volume":"1951","author":"Den Naturst V.","year":"1944","unstructured":"Den Naturst V.; Liislich B.;  Synthese 1944,1951,31","journal-title":"Synthese"},{"key":"ref=11","first-page":"1","volume":"2","author":"Gaikwad P.L.","year":"2012","unstructured":"Gaikwad P.L.; Gandhi P.S.; Jagdale D.M.; Kadam V.J.; The use of bioisosterism in drug design and molecular modification. Am. J. PharmTech. Res 2012,2(4),1-23","journal-title":"Res"},{"key":"ref=12","author":"Burger A.","year":"2003","unstructured":"Burger A.; Abraham D.J.;  Burger's Medicinal Chemistry and Drug Discovery 2003","journal-title":"Burger's Medicinal Chemistry and Drug Discovery"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"186-210","DOI":"10.1016\/B978-0-12-409547-2.12290-5","volume":"1-8","author":"Lima L.M.","year":"2017","unstructured":"Lima L.M.; Barreiro E.J.; Beyond bioisosterism: New concepts in drug discovery Comprehensive Medicinal Chemistry III 2017,1-8,186-210","journal-title":"Comprehensive Medicinal Chemistry III"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0065-7743(08)61137-9","volume":"21","author":"Lipinski C.A.","year":"1986","unstructured":"Lipinski C.A.; Bioisosterism in drug design. Annu Rep Med Chem 1986,21(C),283-291","journal-title":"Annu Rep Med Chem"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1039\/cs9790800563","volume":"8","author":"Thornber C.W.","year":"1979","unstructured":"Thornber C.W.; Isosterism and molecular modification in drug design. Chem Soc Rev 1979,8(4),563-580","journal-title":"Chem Soc Rev"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1021\/jm960291f","volume":"39","author":"Cramer R.D.","year":"1996","unstructured":"Cramer R.D.; Clark R.D.; Patterson D.E.; Ferguson A.M.; Bioisosterism as a molecular diversity descriptor: Steric fields of single \u201cto-pomeric\u201d conformers. J Med Chem 1996,39(16),3060-3069","journal-title":"J Med Chem"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2018.00395","volume":"9","author":"Pol\u00eato M.D.","year":"2018","unstructured":"Pol\u00eato M.D.; Rusu V.H.; Grisci B.I.; Dorn M.; Lins R.D.; Verli H.; Aromatic rings commonly used in medicinal chemistry: Force fields comparison and interactions with water toward the design of new chemical entities. Front Pharmacol 2018,9(APR),1-20","journal-title":"Front Pharmacol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1021\/cr950066q","volume":"96","author":"Patani G.A.","year":"1996","unstructured":"Patani G.A.; LaVoie E.J.; Bioisosterism: A rational approach in drug design. Chem Rev 1996,96(8),3147-3176","journal-title":"Chem Rev"},{"key":"ref=19","first-page":"1-5","volume":"1","author":"Yousef F.","year":"2018","unstructured":"Yousef F.; Mansour O.; Herbali J.; Sulfonamides: Historical discovery development (structure-activity relationship notes). In-Vitro In-Vivo In-Silico J 2018,1(1),1-5","journal-title":"In-Vitro In-Vivo In-Silico J"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1021\/ci400128m","volume":"53","author":"Tobergte D.R.","year":"2013","unstructured":"Tobergte D.R.; Curtis S.; An introduction to medicinal chemistry. J Chem Inf Model 2013,53,1689-1699","journal-title":"J Chem Inf Model"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1039\/C8OB02812E","volume":"17","author":"Mykhailiuk P.K.","year":"2019","unstructured":"Mykhailiuk P.K.; Saturated bioisosteres of benzene: Where to go next? Org Biomol Chem 2019,17(11),2839-2849","journal-title":"Org Biomol Chem"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"4100","DOI":"10.1002\/anie.201610456","volume":"56","author":"Chinthakindi P.K.","year":"2017","unstructured":"Chinthakindi P.K.; Naicker T.; Thota N.; Govender T.; Kruger H.G.; Arvidsson P.I.; Sulfonimidamides in medicinal and agricultural chemistry. Angew Chem Int Ed 2017,56(15),4100-4109","journal-title":"Angew Chem Int Ed"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s10295-009-0553-8","volume":"36","author":"Bentley R.","year":"2009","unstructured":"Bentley R.; Different roads to discovery; Prontosil (hence sulfa drugs) and penicillin (hence \u03b2-lactams). J Ind Microbiol Biotechnol 2009,36(6),775-786","journal-title":"J Ind Microbiol Biotechnol"},{"key":"ref=24","author":"Tripathi K.","year":"2019","unstructured":"Tripathi K.;  Essentials of Medical Pharmacology 2019","journal-title":"Essentials of Medical Pharmacology"},{"key":"ref=25","first-page":"1","author":"Abraham D.J.","year":"1998","unstructured":"Abraham D.J.;  Burger\u2019s Medicinal Chemistry and Drug Discovery 1998,1","journal-title":"Burger\u2019s Medicinal Chemistry and Drug Discovery"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/S1074-5521(01)00079-5","volume":"8","author":"Chen C.A.","year":"2001","unstructured":"Chen C.A.; Sieburth S.M.N.; Glekas A.; Hewitt G.W.; Trainor G.L.; Erickson-Viitanen S.; Drug design with a new transition state analog of the hydrated carbonyl: Silicon-based inhibitors of the HIV protease. Chem Biol 2001,8(12),1161-1166","journal-title":"Chem Biol"},{"key":"ref=27","first-page":"8","volume":"2","author":"Harbeson S.L.","year":"2014","unstructured":"Harbeson S.L.; Tung R.D.; Deuterium medicinal chemistry: A new approach to drug discovery and development. Medchem. News 2014,2,8-22","journal-title":"News"},{"key":"ref=28","first-page":"13","volume":"8","author":"Vald\u00e9s E.","year":"2019","unstructured":"Vald\u00e9s E.; Cuevas-ya\u00f1ez E.; Design and synthesis of antifungal compounds from 1, 2, 3-triazoles through the click chemistry approach. Org Med Chem Int J 2019,8(2),13-15","journal-title":"Org Med Chem Int J"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ejmech.2018.08.094","volume":"158","author":"Giraudo A.","year":"2018","unstructured":"Giraudo A.; Krall J.; Nielsen B.; S\u00f8rensen T.E.; Kongstad K.T.; Rolando B.; 4-Hydroxy-1,2,3-triazole moiety as bioisostere of the carboxylic acid function: A novel scaffold to probe the orthosteric \u03b3-aminobutyric acid receptor binding site. Eur J Med Chem 2018,158,311-321","journal-title":"Eur J Med Chem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"361","DOI":"10.4155\/fmc-2019-0309","volume":"12","author":"Zafrani Y.","year":"2020","unstructured":"Zafrani Y.; Saphier S.; Gershonov E.; Utilizing the CF2H moiety as a H-bond-donating group in drug discovery. Future Med Chem 2020,12(5),361-365","journal-title":"Future Med Chem"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1016\/j.drudis.2017.05.014","volume":"22","author":"Bonandi E.","year":"2017","unstructured":"Bonandi E.; Christodoulou M.S.; Fumagalli G.; Perdicchia D.; Rastelli G.; Passarella D.; The 1,2,3-triazole ring as a bioisostere in me-dicinal chemistry. Drug Discov Today 2017,22(10),1572-1581","journal-title":"Drug Discov Today"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0165-7208(97)80025-6","volume":"26","author":"Sharma S.","year":"1997","unstructured":"Sharma S.; Anand N.; Approaches to design and synthesis of antiparasitic drugs. Pharmacochem Libr 1997,26(18),71-123","journal-title":"Pharmacochem Libr"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1365-2885.1990.tb00773.x","volume":"13","author":"McKellar Q.A.","year":"1990","unstructured":"McKellar Q.A.; Scott E.W.; The benzimidazole anthelmintic agents-a review. J Vet Pharmacol Ther 1990,13(3),223-247","journal-title":"J Vet Pharmacol Ther"},{"key":"ref=34","first-page":"128","volume":"38","author":"Yagiela J.A.","year":"1991","unstructured":"Yagiela J.A.; Local anesthetics. Anesth Prog 1991,38(4-5),128-141","journal-title":"Anesth Prog"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2174\/1568026013395335","volume":"1","author":"Ruetsch Y.","year":"2005","unstructured":"Ruetsch Y.; Boni T.; Borgeat A.; From cocaine to ropivacaine: The history of local anesthetic drugs. Curr Top Med Chem 2005,1(3),175-182","journal-title":"Curr Top Med Chem"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s11103-012-9886-1","volume":"78","author":"Docimo T.","year":"2012","unstructured":"Docimo T.; Reichelt M.; Schneider B.; Kai M.; Kunert G.; Gershenzon J.; The first step in the biosynthesis of cocaine in Erythroxylum coca: The characterization of arginine and ornithine decarboxylases. Plant Mol Biol 2012,78(6),599-615","journal-title":"Plant Mol Biol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/j.1528-1157.1975.tb04742.x","volume":"16","author":"V\u00e1zquez A.J.","year":"1975","unstructured":"V\u00e1zquez A.J.; Diamond B.I.; Sabelli H.C.; Differential effects of phenobarbital and pentobarbital on isolated nervous tissue. Epilepsia 1975,16(4),601-608","journal-title":"Epilepsia"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"R112","DOI":"10.1186\/cc6999","volume":"12","author":"P\u00e9rez-B\u00e1rcena J.","year":"2008","unstructured":"P\u00e9rez-B\u00e1rcena J.; Llompart-Pou J.A.; Homar J.; Pentobarbital versus thiopental in the treatment of refractory intracranial hypertension in patients with traumatic brain injury: A randomized controlled trial. Crit Care 2008,12,R112","journal-title":"Crit Care"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/B0-12-369400-0\/00753-5","author":"Weber J.","year":"2005","unstructured":"Weber J.; Phenothiazines. Encyclopedia of Toxicology 2005,399-401","journal-title":"Encyclopedia of Toxicology"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.bmcl.2018.12.036","volume":"29","author":"Wu J-W.","year":"2019","unstructured":"Wu J-W.; Yin L.; Liu Y-Q.; Zhang H.; Xie Y-F.; Wang R-L.; Zhao G-L.; Synthesis, biological evaluation and 3D-QSAR studies of 1,2,4-triazole-5-substituted carboxylic acid bioisosteres as uric acid transporter 1 (URAT1) inhibitors for the treatment of hyperuricemia associated with gout. Bioorg Med Chem Lett 2019,29(3),383-388","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.drudis.2011.01.001","volume":"16","author":"Ohlow M.J.","year":"2011","unstructured":"Ohlow M.J.; Moosmann B.; Phenothiazine: The seven lives of pharmacology\u2019s first lead structure. Drug Discov Today 2011,16(3-4),119-131","journal-title":"Drug Discov Today"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/minf.201400037","volume":"33","author":"Brown N.","year":"2014","unstructured":"Brown N.; Bioisosteres and scaffold hopping in medicinal chemistry. Mol Inform 2014,33(6-7),458-462","journal-title":"Mol Inform"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/B978-0-323-39307-2.00028-X","author":"Shaw D.H.","year":"2017","unstructured":"Shaw D.H.;  Pharmacology and Therapeutics for Dentistry 2017,404-416","journal-title":"Pharmacology and Therapeutics for Dentistry"},{"key":"ref=44","first-page":"649","volume":"2","author":"Wermuth C.G.","year":"2006","unstructured":"Wermuth C.G.; Ciapetti P.; Giethlen B.; Bazzini P.; Bioisosterism. Compr Med Chem II 2006,2,649-711","journal-title":"Compr Med Chem II"},{"key":"ref=45","first-page":"259-262","author":"Shin J.M.","year":"2004","unstructured":"Shin J.M.; Sachs G.; Proton pump inhibitors. Encyclopedia of Gastroenterology 2004,259-262","journal-title":"Encyclopedia of Gastroenterology"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"27","DOI":"10.5009\/gnl15502","volume":"11","author":"Strand D.S.","year":"2017","unstructured":"Strand D.S.; Kim D.; Peura D.A.; 25 years of proton pump inhibitors: A comprehensive review. Gut Liver 2017,11(1),27-37","journal-title":"Gut Liver"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.3390\/molecules22081210","volume":"22","author":"Gomes M.N.","year":"2017","unstructured":"Gomes M.N.; Muratov E.N.; Pereira M.; Peixoto J.C.; Rosseto L.P.; Cravo P.V.L.; Chalcone derivatives: Promising starting points for drug design. Molecules 2017,22(8),1210","journal-title":"Molecules"},{"key":"ref=48","first-page":"489","volume":"53","author":"Jayashree B.","year":"2015","unstructured":"Jayashree B.; Nigam S.; Pai A.; Patel H.K.; Reddy N.; Kumar N.; Targets in anticancer research-A review. Indian J Exp Biol 2015,53(8),489-507","journal-title":"Indian J Exp Biol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"S313","DOI":"10.5530\/ijper.53.3s.101","volume":"53","author":"Pai A.","year":"2019","unstructured":"Pai A.; Jayashree B.S.; Design, synthesis and biological evaluation of novel piperidinyl chalcones. Indian. J Pharm Educ Res 2019,53(3),S313-S324","journal-title":"J Pharm Educ Res"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.phytochem.2017.01.002","volume":"136","author":"Alam A.","year":"2017","unstructured":"Alam A.; Jaiswal V.; Akhtar S.; Jayashree B.S.; Dhar K.L.; Isolation of isoflavones from Iris kashmiriana Baker as potential anti prolif-erative agents targeting NF-kappaB. Phytochemistry 2017,136,70-80","journal-title":"Phytochemistry"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jmgm.2016.12.002","volume":"72","author":"Basu Mallik S.","year":"2017","unstructured":"Basu Mallik S.; Pai A.; Shenoy R.R.; Jayashree B.S.; Novel flavonol analogues as potential inhibitors of JMJD3 histone demethylase-A study based on molecular modelling. J Mol Graph Model 2017,72,81-87","journal-title":"J Mol Graph Model"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s11164-017-3143-9","volume":"44","author":"Nigam S.","year":"2018","unstructured":"Nigam S.; Jayashree B.S.; Pande A.N.; Reddy N.D.; Venkata Rao J.; Investigating the potential of tetrahydropyridinyl chalcones as use-ful agents against breast carcinoma: An in vitro and in vivo study. Res Chem Intermed 2018,44(2),901-924","journal-title":"Res Chem Intermed"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1007\/s11164-016-2797-z","volume":"43","author":"Nigam S.","year":"2017","unstructured":"Nigam S.; Jayashree B.S.; Limitation of Algar-Flynn-Oyamada reaction using methoxy substituted chalcones as reactants and evaluation of the newly transformed aurones for their biological activities. Res Chem Intermed 2017,43(5),2839-2864","journal-title":"Res Chem Intermed"},{"key":"ref=54","first-page":"448","volume":"16","author":"Pande A.N.","year":"2017","unstructured":"Pande A.N.; Biswas S.; Reddy N.D.; Jayashree B.S.; Kumar N.; Rao C.M.; In vitro and in vivo anticancer studies of 2\u2032-hydroxy chal-cone derivatives exhibit apoptosis in colon cancer cells by hdac inhibition and cell cycle arrest. EXCLI J 2017,16,448-463","journal-title":"EXCLI J"}],"container-title":["Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573406418666220127124228","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/200599\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573406418666220127124228","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T18:14:35Z","timestamp":1693160075000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/200599\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":54,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573406418666220127124228","relation":{},"ISSN":["1573-4064"],"issn-type":[{"value":"1573-4064","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-09-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-28","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}